JPH0466514A - Cosmetic - Google Patents
CosmeticInfo
- Publication number
- JPH0466514A JPH0466514A JP17365090A JP17365090A JPH0466514A JP H0466514 A JPH0466514 A JP H0466514A JP 17365090 A JP17365090 A JP 17365090A JP 17365090 A JP17365090 A JP 17365090A JP H0466514 A JPH0466514 A JP H0466514A
- Authority
- JP
- Japan
- Prior art keywords
- extract
- cosmetic
- preparation example
- effect
- extract obtained
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 239000002537 cosmetic Substances 0.000 title claims abstract description 44
- 239000000284 extract Substances 0.000 claims abstract description 103
- 241000237858 Gastropoda Species 0.000 claims abstract description 25
- 210000001835 viscera Anatomy 0.000 claims description 27
- 108091005804 Peptidases Proteins 0.000 claims description 13
- 102000035195 Peptidases Human genes 0.000 claims description 13
- 230000000694 effects Effects 0.000 abstract description 39
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 abstract description 26
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 abstract description 22
- 239000006210 lotion Substances 0.000 abstract description 18
- 239000007787 solid Substances 0.000 abstract description 15
- 102000003425 Tyrosinase Human genes 0.000 abstract description 14
- 108060008724 Tyrosinase Proteins 0.000 abstract description 14
- 230000003020 moisturizing effect Effects 0.000 abstract description 12
- -1 pH-conditioner Substances 0.000 abstract description 10
- 239000006071 cream Substances 0.000 abstract description 7
- 239000003921 oil Substances 0.000 abstract description 7
- 239000003974 emollient agent Substances 0.000 abstract description 6
- 239000002904 solvent Substances 0.000 abstract description 6
- 239000003963 antioxidant agent Substances 0.000 abstract description 3
- 238000003287 bathing Methods 0.000 abstract description 3
- 239000003906 humectant Substances 0.000 abstract description 3
- 239000000344 soap Substances 0.000 abstract description 3
- 239000004094 surface-active agent Substances 0.000 abstract description 3
- 239000002562 thickening agent Substances 0.000 abstract description 3
- 239000006096 absorbing agent Substances 0.000 abstract description 2
- 230000003078 antioxidant effect Effects 0.000 abstract description 2
- 239000003795 chemical substances by application Substances 0.000 abstract description 2
- 239000003925 fat Substances 0.000 abstract description 2
- 241000143510 Haliotis discus hannai Species 0.000 abstract 1
- 241000237983 Trochidae Species 0.000 abstract 1
- 238000013329 compounding Methods 0.000 abstract 1
- 230000001747 exhibiting effect Effects 0.000 abstract 1
- 239000002304 perfume Substances 0.000 abstract 1
- 239000003981 vehicle Substances 0.000 abstract 1
- 238000010792 warming Methods 0.000 abstract 1
- 238000002360 preparation method Methods 0.000 description 67
- 239000000203 mixture Substances 0.000 description 34
- 238000009472 formulation Methods 0.000 description 31
- 239000000843 powder Substances 0.000 description 17
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 description 16
- 239000008213 purified water Substances 0.000 description 15
- 239000000243 solution Substances 0.000 description 15
- LXCFILQKKLGQFO-UHFFFAOYSA-N methylparaben Chemical compound COC(=O)C1=CC=C(O)C=C1 LXCFILQKKLGQFO-UHFFFAOYSA-N 0.000 description 14
- 238000012360 testing method Methods 0.000 description 14
- 239000004615 ingredient Substances 0.000 description 13
- 238000004519 manufacturing process Methods 0.000 description 12
- 230000000052 comparative effect Effects 0.000 description 11
- DNIAPMSPPWPWGF-UHFFFAOYSA-N Propylene glycol Chemical compound CC(O)CO DNIAPMSPPWPWGF-UHFFFAOYSA-N 0.000 description 9
- 239000004365 Protease Substances 0.000 description 9
- 235000019441 ethanol Nutrition 0.000 description 9
- 238000002835 absorbance Methods 0.000 description 8
- 238000000605 extraction Methods 0.000 description 8
- 235000011187 glycerol Nutrition 0.000 description 8
- 235000019419 proteases Nutrition 0.000 description 8
- 239000000654 additive Substances 0.000 description 7
- 239000003205 fragrance Substances 0.000 description 7
- 235000010270 methyl p-hydroxybenzoate Nutrition 0.000 description 7
- 239000004292 methyl p-hydroxybenzoate Substances 0.000 description 7
- 229960002216 methylparaben Drugs 0.000 description 7
- 238000002156 mixing Methods 0.000 description 7
- 239000002453 shampoo Substances 0.000 description 7
- VBICKXHEKHSIBG-UHFFFAOYSA-N 1-monostearoylglycerol Chemical compound CCCCCCCCCCCCCCCCCC(=O)OCC(O)CO VBICKXHEKHSIBG-UHFFFAOYSA-N 0.000 description 6
- CSCPPACGZOOCGX-UHFFFAOYSA-N Acetone Chemical compound CC(C)=O CSCPPACGZOOCGX-UHFFFAOYSA-N 0.000 description 6
- 150000001413 amino acids Chemical class 0.000 description 6
- 239000013040 bath agent Substances 0.000 description 6
- KRKNYBCHXYNGOX-UHFFFAOYSA-N citric acid Chemical compound OC(=O)CC(O)(C(O)=O)CC(O)=O KRKNYBCHXYNGOX-UHFFFAOYSA-N 0.000 description 6
- 235000019198 oils Nutrition 0.000 description 6
- 239000002245 particle Substances 0.000 description 6
- QELSKZZBTMNZEB-UHFFFAOYSA-N propylparaben Chemical compound CCCOC(=O)C1=CC=C(O)C=C1 QELSKZZBTMNZEB-UHFFFAOYSA-N 0.000 description 6
- 241000894431 Turbinidae Species 0.000 description 5
- 239000007864 aqueous solution Substances 0.000 description 5
- 239000000839 emulsion Substances 0.000 description 5
- 238000010438 heat treatment Methods 0.000 description 5
- PUPZLCDOIYMWBV-UHFFFAOYSA-N (+/-)-1,3-Butanediol Chemical compound CC(O)CCO PUPZLCDOIYMWBV-UHFFFAOYSA-N 0.000 description 4
- 241000237967 Aplysia Species 0.000 description 4
- QFOHBWFCKVYLES-UHFFFAOYSA-N Butylparaben Chemical compound CCCCOC(=O)C1=CC=C(O)C=C1 QFOHBWFCKVYLES-UHFFFAOYSA-N 0.000 description 4
- UQSXHKLRYXJYBZ-UHFFFAOYSA-N Iron oxide Chemical compound [Fe]=O UQSXHKLRYXJYBZ-UHFFFAOYSA-N 0.000 description 4
- UIIMBOGNXHQVGW-UHFFFAOYSA-M Sodium bicarbonate Chemical compound [Na+].OC([O-])=O UIIMBOGNXHQVGW-UHFFFAOYSA-M 0.000 description 4
- 206010044625 Trichorrhexis Diseases 0.000 description 4
- 230000000996 additive effect Effects 0.000 description 4
- 238000004458 analytical method Methods 0.000 description 4
- 230000036760 body temperature Effects 0.000 description 4
- NOPFSRXAKWQILS-UHFFFAOYSA-N docosan-1-ol Chemical compound CCCCCCCCCCCCCCCCCCCCCCO NOPFSRXAKWQILS-UHFFFAOYSA-N 0.000 description 4
- 239000007788 liquid Substances 0.000 description 4
- 229940057995 liquid paraffin Drugs 0.000 description 4
- 238000000034 method Methods 0.000 description 4
- 239000001509 sodium citrate Substances 0.000 description 4
- NLJMYIDDQXHKNR-UHFFFAOYSA-K sodium citrate Chemical compound O.O.[Na+].[Na+].[Na+].[O-]C(=O)CC(O)(CC([O-])=O)C([O-])=O NLJMYIDDQXHKNR-UHFFFAOYSA-K 0.000 description 4
- PRAKJMSDJKAYCZ-UHFFFAOYSA-N squalane Chemical compound CC(C)CCCC(C)CCCC(C)CCCCC(C)CCCC(C)CCCC(C)C PRAKJMSDJKAYCZ-UHFFFAOYSA-N 0.000 description 4
- 238000003756 stirring Methods 0.000 description 4
- 230000002087 whitening effect Effects 0.000 description 4
- UHOVQNZJYSORNB-UHFFFAOYSA-N Benzene Chemical compound C1=CC=CC=C1 UHOVQNZJYSORNB-UHFFFAOYSA-N 0.000 description 3
- YMWUJEATGCHHMB-UHFFFAOYSA-N Dichloromethane Chemical compound ClCCl YMWUJEATGCHHMB-UHFFFAOYSA-N 0.000 description 3
- XEKOWRVHYACXOJ-UHFFFAOYSA-N Ethyl acetate Chemical compound CCOC(C)=O XEKOWRVHYACXOJ-UHFFFAOYSA-N 0.000 description 3
- LYCAIKOWRPUZTN-UHFFFAOYSA-N Ethylene glycol Chemical compound OCCO LYCAIKOWRPUZTN-UHFFFAOYSA-N 0.000 description 3
- OKKJLVBELUTLKV-UHFFFAOYSA-N Methanol Chemical compound OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 description 3
- YXFVVABEGXRONW-UHFFFAOYSA-N Toluene Chemical compound CC1=CC=CC=C1 YXFVVABEGXRONW-UHFFFAOYSA-N 0.000 description 3
- 108090000631 Trypsin Proteins 0.000 description 3
- 102000004142 Trypsin Human genes 0.000 description 3
- 239000002253 acid Substances 0.000 description 3
- 239000001768 carboxy methyl cellulose Substances 0.000 description 3
- 229960000541 cetyl alcohol Drugs 0.000 description 3
- 238000001816 cooling Methods 0.000 description 3
- 239000000796 flavoring agent Substances 0.000 description 3
- 235000019634 flavors Nutrition 0.000 description 3
- 229940075507 glyceryl monostearate Drugs 0.000 description 3
- BXWNKGSJHAJOGX-UHFFFAOYSA-N hexadecan-1-ol Chemical compound CCCCCCCCCCCCCCCCO BXWNKGSJHAJOGX-UHFFFAOYSA-N 0.000 description 3
- 239000002932 luster Substances 0.000 description 3
- 239000001788 mono and diglycerides of fatty acids Substances 0.000 description 3
- VLKZOEOYAKHREP-UHFFFAOYSA-N n-Hexane Chemical compound CCCCCC VLKZOEOYAKHREP-UHFFFAOYSA-N 0.000 description 3
- 235000014593 oils and fats Nutrition 0.000 description 3
- 235000010232 propyl p-hydroxybenzoate Nutrition 0.000 description 3
- 239000004405 propyl p-hydroxybenzoate Substances 0.000 description 3
- 229960003415 propylparaben Drugs 0.000 description 3
- 102000004169 proteins and genes Human genes 0.000 description 3
- 108090000623 proteins and genes Proteins 0.000 description 3
- 239000012588 trypsin Substances 0.000 description 3
- 229940058015 1,3-butylene glycol Drugs 0.000 description 2
- JLPULHDHAOZNQI-ZTIMHPMXSA-N 1-hexadecanoyl-2-(9Z,12Z-octadecadienoyl)-sn-glycero-3-phosphocholine Chemical compound CCCCCCCCCCCCCCCC(=O)OC[C@H](COP([O-])(=O)OCC[N+](C)(C)C)OC(=O)CCCCCCC\C=C/C\C=C/CCCCC JLPULHDHAOZNQI-ZTIMHPMXSA-N 0.000 description 2
- 241000416162 Astragalus gummifer Species 0.000 description 2
- 241000972773 Aulopiformes Species 0.000 description 2
- 240000008574 Capsicum frutescens Species 0.000 description 2
- 229920002134 Carboxymethyl cellulose Polymers 0.000 description 2
- 239000004287 Dehydroacetic acid Substances 0.000 description 2
- 206010014970 Ephelides Diseases 0.000 description 2
- 239000004354 Hydroxyethyl cellulose Substances 0.000 description 2
- 229920000663 Hydroxyethyl cellulose Polymers 0.000 description 2
- XEEYBQQBJWHFJM-UHFFFAOYSA-N Iron Chemical compound [Fe] XEEYBQQBJWHFJM-UHFFFAOYSA-N 0.000 description 2
- 208000003351 Melanosis Diseases 0.000 description 2
- 239000004909 Moisturizer Substances 0.000 description 2
- 239000004677 Nylon Substances 0.000 description 2
- NBIIXXVUZAFLBC-UHFFFAOYSA-N Phosphoric acid Chemical compound OP(O)(O)=O NBIIXXVUZAFLBC-UHFFFAOYSA-N 0.000 description 2
- 229920003171 Poly (ethylene oxide) Polymers 0.000 description 2
- 239000004372 Polyvinyl alcohol Substances 0.000 description 2
- 208000006981 Skin Abnormalities Diseases 0.000 description 2
- PMZURENOXWZQFD-UHFFFAOYSA-L Sodium Sulfate Chemical compound [Na+].[Na+].[O-]S([O-])(=O)=O PMZURENOXWZQFD-UHFFFAOYSA-L 0.000 description 2
- 229920002125 Sokalan® Polymers 0.000 description 2
- HVUMOYIDDBPOLL-XWVZOOPGSA-N Sorbitan monostearate Chemical compound CCCCCCCCCCCCCCCCCC(=O)OC[C@@H](O)[C@H]1OC[C@H](O)[C@H]1O HVUMOYIDDBPOLL-XWVZOOPGSA-N 0.000 description 2
- VBIIFPGSPJYLRR-UHFFFAOYSA-M Stearyltrimethylammonium chloride Chemical compound [Cl-].CCCCCCCCCCCCCCCCCC[N+](C)(C)C VBIIFPGSPJYLRR-UHFFFAOYSA-M 0.000 description 2
- GWEVSGVZZGPLCZ-UHFFFAOYSA-N Titan oxide Chemical compound O=[Ti]=O GWEVSGVZZGPLCZ-UHFFFAOYSA-N 0.000 description 2
- 229920001615 Tragacanth Polymers 0.000 description 2
- 150000001298 alcohols Chemical class 0.000 description 2
- 235000019437 butane-1,3-diol Nutrition 0.000 description 2
- 229940067596 butylparaben Drugs 0.000 description 2
- 235000010948 carboxy methyl cellulose Nutrition 0.000 description 2
- 239000008112 carboxymethyl-cellulose Substances 0.000 description 2
- 239000008406 cosmetic ingredient Substances 0.000 description 2
- PGRHXDWITVMQBC-UHFFFAOYSA-N dehydroacetic acid Natural products CC(=O)C1C(=O)OC(C)=CC1=O PGRHXDWITVMQBC-UHFFFAOYSA-N 0.000 description 2
- 235000019258 dehydroacetic acid Nutrition 0.000 description 2
- JEQRBTDTEKWZBW-UHFFFAOYSA-N dehydroacetic acid Chemical compound CC(=O)C1=C(O)OC(C)=CC1=O JEQRBTDTEKWZBW-UHFFFAOYSA-N 0.000 description 2
- 229940061632 dehydroacetic acid Drugs 0.000 description 2
- 229960000735 docosanol Drugs 0.000 description 2
- LQZZUXJYWNFBMV-UHFFFAOYSA-N dodecan-1-ol Chemical compound CCCCCCCCCCCCO LQZZUXJYWNFBMV-UHFFFAOYSA-N 0.000 description 2
- 239000003995 emulsifying agent Substances 0.000 description 2
- 150000002148 esters Chemical class 0.000 description 2
- 229960001617 ethyl hydroxybenzoate Drugs 0.000 description 2
- 235000010228 ethyl p-hydroxybenzoate Nutrition 0.000 description 2
- 239000004403 ethyl p-hydroxybenzoate Substances 0.000 description 2
- NUVBSKCKDOMJSU-UHFFFAOYSA-N ethylparaben Chemical compound CCOC(=O)C1=CC=C(O)C=C1 NUVBSKCKDOMJSU-UHFFFAOYSA-N 0.000 description 2
- YMAWOPBAYDPSLA-UHFFFAOYSA-N glycylglycine Chemical compound [NH3+]CC(=O)NCC([O-])=O YMAWOPBAYDPSLA-UHFFFAOYSA-N 0.000 description 2
- 239000003676 hair preparation Substances 0.000 description 2
- 235000019447 hydroxyethyl cellulose Nutrition 0.000 description 2
- 229920003063 hydroxymethyl cellulose Polymers 0.000 description 2
- 229940031574 hydroxymethyl cellulose Drugs 0.000 description 2
- WTFXARWRTYJXII-UHFFFAOYSA-N iron(2+);iron(3+);oxygen(2-) Chemical compound [O-2].[O-2].[O-2].[O-2].[Fe+2].[Fe+3].[Fe+3] WTFXARWRTYJXII-UHFFFAOYSA-N 0.000 description 2
- SZVJSHCCFOBDDC-UHFFFAOYSA-N iron(II,III) oxide Inorganic materials O=[Fe]O[Fe]O[Fe]=O SZVJSHCCFOBDDC-UHFFFAOYSA-N 0.000 description 2
- 229940119170 jojoba wax Drugs 0.000 description 2
- JVTAAEKCZFNVCJ-UHFFFAOYSA-N lactic acid Chemical compound CC(O)C(O)=O JVTAAEKCZFNVCJ-UHFFFAOYSA-N 0.000 description 2
- CSNNHWWHGAXBCP-UHFFFAOYSA-L magnesium sulphate Substances [Mg+2].[O-][S+2]([O-])([O-])[O-] CSNNHWWHGAXBCP-UHFFFAOYSA-L 0.000 description 2
- 235000019341 magnesium sulphate Nutrition 0.000 description 2
- 230000004060 metabolic process Effects 0.000 description 2
- 239000010445 mica Substances 0.000 description 2
- 229910052618 mica group Inorganic materials 0.000 description 2
- 230000001333 moisturizer Effects 0.000 description 2
- JXTPJDDICSTXJX-UHFFFAOYSA-N n-Triacontane Natural products CCCCCCCCCCCCCCCCCCCCCCCCCCCCCC JXTPJDDICSTXJX-UHFFFAOYSA-N 0.000 description 2
- 229920001778 nylon Polymers 0.000 description 2
- GLDOVTGHNKAZLK-UHFFFAOYSA-N octadecan-1-ol Chemical compound CCCCCCCCCCCCCCCCCCO GLDOVTGHNKAZLK-UHFFFAOYSA-N 0.000 description 2
- 239000012188 paraffin wax Substances 0.000 description 2
- 239000000546 pharmaceutical excipient Substances 0.000 description 2
- 239000008363 phosphate buffer Substances 0.000 description 2
- 239000000049 pigment Substances 0.000 description 2
- 239000001818 polyoxyethylene sorbitan monostearate Substances 0.000 description 2
- 235000010989 polyoxyethylene sorbitan monostearate Nutrition 0.000 description 2
- 229920002451 polyvinyl alcohol Polymers 0.000 description 2
- 239000003755 preservative agent Substances 0.000 description 2
- 229940024999 proteolytic enzymes for treatment of wounds and ulcers Drugs 0.000 description 2
- 238000011160 research Methods 0.000 description 2
- 235000019515 salmon Nutrition 0.000 description 2
- 235000017557 sodium bicarbonate Nutrition 0.000 description 2
- 229910000030 sodium bicarbonate Inorganic materials 0.000 description 2
- 229910052938 sodium sulfate Inorganic materials 0.000 description 2
- 235000011152 sodium sulphate Nutrition 0.000 description 2
- 239000001587 sorbitan monostearate Substances 0.000 description 2
- 235000011076 sorbitan monostearate Nutrition 0.000 description 2
- 229940035048 sorbitan monostearate Drugs 0.000 description 2
- 229940083466 soybean lecithin Drugs 0.000 description 2
- 229940032094 squalane Drugs 0.000 description 2
- 239000000454 talc Substances 0.000 description 2
- 229910052623 talc Inorganic materials 0.000 description 2
- 239000003760 tallow Substances 0.000 description 2
- OGIDPMRJRNCKJF-UHFFFAOYSA-N titanium oxide Inorganic materials [Ti]=O OGIDPMRJRNCKJF-UHFFFAOYSA-N 0.000 description 2
- VLPFTAMPNXLGLX-UHFFFAOYSA-N trioctanoin Chemical compound CCCCCCCC(=O)OCC(OC(=O)CCCCCCC)COC(=O)CCCCCCC VLPFTAMPNXLGLX-UHFFFAOYSA-N 0.000 description 2
- KIUKXJAPPMFGSW-DNGZLQJQSA-N (2S,3S,4S,5R,6R)-6-[(2S,3R,4R,5S,6R)-3-Acetamido-2-[(2S,3S,4R,5R,6R)-6-[(2R,3R,4R,5S,6R)-3-acetamido-2,5-dihydroxy-6-(hydroxymethyl)oxan-4-yl]oxy-2-carboxy-4,5-dihydroxyoxan-3-yl]oxy-5-hydroxy-6-(hydroxymethyl)oxan-4-yl]oxy-3,4,5-trihydroxyoxane-2-carboxylic acid Chemical compound CC(=O)N[C@H]1[C@H](O)O[C@H](CO)[C@@H](O)[C@@H]1O[C@H]1[C@H](O)[C@@H](O)[C@H](O[C@H]2[C@@H]([C@@H](O[C@H]3[C@@H]([C@@H](O)[C@H](O)[C@H](O3)C(O)=O)O)[C@H](O)[C@@H](CO)O2)NC(C)=O)[C@@H](C(O)=O)O1 KIUKXJAPPMFGSW-DNGZLQJQSA-N 0.000 description 1
- ALSTYHKOOCGGFT-KTKRTIGZSA-N (9Z)-octadecen-1-ol Chemical compound CCCCCCCC\C=C/CCCCCCCCO ALSTYHKOOCGGFT-KTKRTIGZSA-N 0.000 description 1
- KBPLFHHGFOOTCA-UHFFFAOYSA-N 1-Octanol Chemical compound CCCCCCCCO KBPLFHHGFOOTCA-UHFFFAOYSA-N 0.000 description 1
- JRMXMUCILWKNNW-UHFFFAOYSA-N 1-butoxy-2-methylbenzene Chemical compound CCCCOC1=CC=CC=C1C JRMXMUCILWKNNW-UHFFFAOYSA-N 0.000 description 1
- FUTGDWNFCMWSJT-UHFFFAOYSA-N 2,3-bis(14-methylpentadecanoyloxy)propyl 14-methylpentadecanoate Chemical compound CC(C)CCCCCCCCCCCCC(=O)OCC(OC(=O)CCCCCCCCCCCCC(C)C)COC(=O)CCCCCCCCCCCCC(C)C FUTGDWNFCMWSJT-UHFFFAOYSA-N 0.000 description 1
- DGSZGZSCHSQXFV-UHFFFAOYSA-N 2,3-bis(2-ethylhexanoyloxy)propyl 2-ethylhexanoate Chemical compound CCCCC(CC)C(=O)OCC(OC(=O)C(CC)CCCC)COC(=O)C(CC)CCCC DGSZGZSCHSQXFV-UHFFFAOYSA-N 0.000 description 1
- LIFHMKCDDVTICL-UHFFFAOYSA-N 6-(chloromethyl)phenanthridine Chemical compound C1=CC=C2C(CCl)=NC3=CC=CC=C3C2=C1 LIFHMKCDDVTICL-UHFFFAOYSA-N 0.000 description 1
- 239000004215 Carbon black (E152) Substances 0.000 description 1
- 108090001069 Chymopapain Proteins 0.000 description 1
- 108090000317 Chymotrypsin Proteins 0.000 description 1
- 102000008186 Collagen Human genes 0.000 description 1
- 108010035532 Collagen Proteins 0.000 description 1
- 102000016942 Elastin Human genes 0.000 description 1
- 108010014258 Elastin Proteins 0.000 description 1
- 102000004190 Enzymes Human genes 0.000 description 1
- 108090000790 Enzymes Proteins 0.000 description 1
- 108010008488 Glycylglycine Proteins 0.000 description 1
- 241000237891 Haliotidae Species 0.000 description 1
- OUYCCCASQSFEME-QMMMGPOBSA-N L-tyrosine Chemical compound OC(=O)[C@@H](N)CC1=CC=C(O)C=C1 OUYCCCASQSFEME-QMMMGPOBSA-N 0.000 description 1
- 241000761557 Lamina Species 0.000 description 1
- 241001465754 Metazoa Species 0.000 description 1
- AOMUHOFOVNGZAN-UHFFFAOYSA-N N,N-bis(2-hydroxyethyl)dodecanamide Chemical compound CCCCCCCCCCCC(=O)N(CCO)CCO AOMUHOFOVNGZAN-UHFFFAOYSA-N 0.000 description 1
- 241000772415 Neovison vison Species 0.000 description 1
- 108090000526 Papain Proteins 0.000 description 1
- 102000057297 Pepsin A Human genes 0.000 description 1
- 108090000284 Pepsin A Proteins 0.000 description 1
- DBMJMQXJHONAFJ-UHFFFAOYSA-M Sodium laurylsulphate Chemical compound [Na+].CCCCCCCCCCCCOS([O-])(=O)=O DBMJMQXJHONAFJ-UHFFFAOYSA-M 0.000 description 1
- 229930006000 Sucrose Natural products 0.000 description 1
- ISWQCIVKKSOKNN-UHFFFAOYSA-L Tiron Chemical compound [Na+].[Na+].OC1=CC(S([O-])(=O)=O)=CC(S([O-])(=O)=O)=C1O ISWQCIVKKSOKNN-UHFFFAOYSA-L 0.000 description 1
- 102100034392 Trypsin-2 Human genes 0.000 description 1
- 101710119666 Trypsin-2 Proteins 0.000 description 1
- 230000005856 abnormality Effects 0.000 description 1
- 230000037374 absorbed through the skin Effects 0.000 description 1
- DPXJVFZANSGRMM-UHFFFAOYSA-N acetic acid;2,3,4,5,6-pentahydroxyhexanal;sodium Chemical compound [Na].CC(O)=O.OCC(O)C(O)C(O)C(O)C=O DPXJVFZANSGRMM-UHFFFAOYSA-N 0.000 description 1
- 230000003213 activating effect Effects 0.000 description 1
- 239000013543 active substance Substances 0.000 description 1
- ZOJBYZNEUISWFT-UHFFFAOYSA-N allyl isothiocyanate Chemical compound C=CCN=C=S ZOJBYZNEUISWFT-UHFFFAOYSA-N 0.000 description 1
- 229910000147 aluminium phosphate Inorganic materials 0.000 description 1
- 239000003945 anionic surfactant Substances 0.000 description 1
- 235000021302 avocado oil Nutrition 0.000 description 1
- 239000008163 avocado oil Substances 0.000 description 1
- 235000015278 beef Nutrition 0.000 description 1
- 229960000686 benzalkonium chloride Drugs 0.000 description 1
- CADWTSSKOVRVJC-UHFFFAOYSA-N benzyl(dimethyl)azanium;chloride Chemical compound [Cl-].C[NH+](C)CC1=CC=CC=C1 CADWTSSKOVRVJC-UHFFFAOYSA-N 0.000 description 1
- 239000012472 biological sample Substances 0.000 description 1
- PLXUFYVBQPIQQH-UHFFFAOYSA-N butoxymethoxybenzene Chemical compound CCCCOCOC1=CC=CC=C1 PLXUFYVBQPIQQH-UHFFFAOYSA-N 0.000 description 1
- 239000003093 cationic surfactant Substances 0.000 description 1
- WOWHHFRSBJGXCM-UHFFFAOYSA-M cetyltrimethylammonium chloride Chemical compound [Cl-].CCCCCCCCCCCCCCCC[N+](C)(C)C WOWHHFRSBJGXCM-UHFFFAOYSA-M 0.000 description 1
- 238000006243 chemical reaction Methods 0.000 description 1
- 229960002976 chymopapain Drugs 0.000 description 1
- 229960002376 chymotrypsin Drugs 0.000 description 1
- 210000000078 claw Anatomy 0.000 description 1
- 239000012459 cleaning agent Substances 0.000 description 1
- 239000003240 coconut oil Substances 0.000 description 1
- 235000019864 coconut oil Nutrition 0.000 description 1
- 229920001436 collagen Polymers 0.000 description 1
- 150000001875 compounds Chemical class 0.000 description 1
- 238000000354 decomposition reaction Methods 0.000 description 1
- 239000002274 desiccant Substances 0.000 description 1
- 239000003599 detergent Substances 0.000 description 1
- 238000011161 development Methods 0.000 description 1
- 235000014113 dietary fatty acids Nutrition 0.000 description 1
- 238000007865 diluting Methods 0.000 description 1
- POULHZVOKOAJMA-UHFFFAOYSA-M dodecanoate Chemical compound CCCCCCCCCCCC([O-])=O POULHZVOKOAJMA-UHFFFAOYSA-M 0.000 description 1
- JZKFHQMONDVVNF-UHFFFAOYSA-N dodecyl sulfate;tris(2-hydroxyethyl)azanium Chemical compound OCCN(CCO)CCO.CCCCCCCCCCCCOS(O)(=O)=O JZKFHQMONDVVNF-UHFFFAOYSA-N 0.000 description 1
- 238000001035 drying Methods 0.000 description 1
- 229920002549 elastin Polymers 0.000 description 1
- 238000005516 engineering process Methods 0.000 description 1
- 229940088598 enzyme Drugs 0.000 description 1
- 229960004756 ethanol Drugs 0.000 description 1
- 150000002170 ethers Chemical class 0.000 description 1
- 238000011156 evaluation Methods 0.000 description 1
- 235000019197 fats Nutrition 0.000 description 1
- 239000000194 fatty acid Substances 0.000 description 1
- 229930195729 fatty acid Natural products 0.000 description 1
- 150000004665 fatty acids Chemical class 0.000 description 1
- 238000000855 fermentation Methods 0.000 description 1
- 230000004151 fermentation Effects 0.000 description 1
- 238000001914 filtration Methods 0.000 description 1
- 229960005150 glycerol Drugs 0.000 description 1
- 125000003976 glyceryl group Chemical group [H]C([*])([H])C(O[H])([H])C(O[H])([H])[H] 0.000 description 1
- 229940043257 glycylglycine Drugs 0.000 description 1
- 239000008187 granular material Substances 0.000 description 1
- 238000000227 grinding Methods 0.000 description 1
- 229920002674 hyaluronan Polymers 0.000 description 1
- 229960003160 hyaluronic acid Drugs 0.000 description 1
- 229930195733 hydrocarbon Natural products 0.000 description 1
- 150000002430 hydrocarbons Chemical class 0.000 description 1
- 230000002401 inhibitory effect Effects 0.000 description 1
- 230000005764 inhibitory process Effects 0.000 description 1
- 229910052742 iron Inorganic materials 0.000 description 1
- LDHBWEYLDHLIBQ-UHFFFAOYSA-M iron(3+);oxygen(2-);hydroxide;hydrate Chemical compound O.[OH-].[O-2].[Fe+3] LDHBWEYLDHLIBQ-UHFFFAOYSA-M 0.000 description 1
- JEIPFZHSYJVQDO-UHFFFAOYSA-N iron(III) oxide Inorganic materials O=[Fe]O[Fe]=O JEIPFZHSYJVQDO-UHFFFAOYSA-N 0.000 description 1
- 150000002576 ketones Chemical class 0.000 description 1
- 239000004310 lactic acid Substances 0.000 description 1
- 235000014655 lactic acid Nutrition 0.000 description 1
- 229940070765 laurate Drugs 0.000 description 1
- 229940031957 lauric acid diethanolamide Drugs 0.000 description 1
- 238000012423 maintenance Methods 0.000 description 1
- 230000008099 melanin synthesis Effects 0.000 description 1
- 230000000813 microbial effect Effects 0.000 description 1
- 239000008164 mustard oil Substances 0.000 description 1
- GOQYKNQRPGWPLP-UHFFFAOYSA-N n-heptadecyl alcohol Natural products CCCCCCCCCCCCCCCCCO GOQYKNQRPGWPLP-UHFFFAOYSA-N 0.000 description 1
- 239000002736 nonionic surfactant Substances 0.000 description 1
- 229940055577 oleyl alcohol Drugs 0.000 description 1
- XMLQWXUVTXCDDL-UHFFFAOYSA-N oleyl alcohol Natural products CCCCCCC=CCCCCCCCCCCO XMLQWXUVTXCDDL-UHFFFAOYSA-N 0.000 description 1
- 239000004006 olive oil Substances 0.000 description 1
- 235000008390 olive oil Nutrition 0.000 description 1
- 239000003002 pH adjusting agent Substances 0.000 description 1
- 229940055729 papain Drugs 0.000 description 1
- 235000019834 papain Nutrition 0.000 description 1
- 229940056211 paraffin Drugs 0.000 description 1
- 239000013618 particulate matter Substances 0.000 description 1
- 229940111202 pepsin Drugs 0.000 description 1
- 210000002826 placenta Anatomy 0.000 description 1
- 229920005862 polyol Polymers 0.000 description 1
- 150000003077 polyols Chemical class 0.000 description 1
- 230000002335 preservative effect Effects 0.000 description 1
- 238000003825 pressing Methods 0.000 description 1
- 229960004063 propylene glycol Drugs 0.000 description 1
- 235000013772 propylene glycol Nutrition 0.000 description 1
- 238000010298 pulverizing process Methods 0.000 description 1
- 229940109850 royal jelly Drugs 0.000 description 1
- 210000004761 scalp Anatomy 0.000 description 1
- 229920002545 silicone oil Polymers 0.000 description 1
- 235000019812 sodium carboxymethyl cellulose Nutrition 0.000 description 1
- 229920001027 sodium carboxymethylcellulose Polymers 0.000 description 1
- 235000019333 sodium laurylsulphate Nutrition 0.000 description 1
- 229940045920 sodium pyrrolidone carboxylate Drugs 0.000 description 1
- HYRLWUFWDYFEES-UHFFFAOYSA-M sodium;2-oxopyrrolidine-1-carboxylate Chemical compound [Na+].[O-]C(=O)N1CCCC1=O HYRLWUFWDYFEES-UHFFFAOYSA-M 0.000 description 1
- 238000001694 spray drying Methods 0.000 description 1
- 239000000126 substance Substances 0.000 description 1
- 239000005720 sucrose Substances 0.000 description 1
- OUYCCCASQSFEME-UHFFFAOYSA-N tyrosine Natural products OC(=O)C(N)CC1=CC=C(O)C=C1 OUYCCCASQSFEME-UHFFFAOYSA-N 0.000 description 1
- 235000015112 vegetable and seed oil Nutrition 0.000 description 1
- 239000008158 vegetable oil Substances 0.000 description 1
- 239000011782 vitamin Substances 0.000 description 1
- 229940088594 vitamin Drugs 0.000 description 1
- 229930003231 vitamin Natural products 0.000 description 1
- 235000013343 vitamin Nutrition 0.000 description 1
- 150000003722 vitamin derivatives Chemical class 0.000 description 1
- 239000003021 water soluble solvent Substances 0.000 description 1
- 230000037303 wrinkles Effects 0.000 description 1
Landscapes
- Cosmetics (AREA)
Abstract
Description
【発明の詳細な説明】
[産業上の利用分野]
本発明は化粧料に関する。さらに詳しくは、基礎化粧品
をはじめ、メイクアップ化粧品、頭髪用化粧品、浴剤な
どに好適に使用しうる化粧料に関する。DETAILED DESCRIPTION OF THE INVENTION [Industrial Field of Application] The present invention relates to cosmetics. More specifically, the present invention relates to cosmetics that can be suitably used in basic cosmetics, make-up cosmetics, hair cosmetics, bath additives, and the like.
[従来の技術]
従来より、すぐれたモイスチャー効果やエモリエント効
果を皮膚に付与し、チロシナーゼの活性を抑制し、保湿
、美白などの総合的な化粧効果を発現する化粧料の開発
が待ち望まれている。[Conventional technology] The development of cosmetics that provide excellent moisturizing and emollient effects to the skin, suppress tyrosinase activity, and provide comprehensive cosmetic effects such as moisturizing and whitening have long been awaited. .
そこで、皮膚からの吸収がよく、生理活性物質を皮膚に
補給することにより皮膚の新陳代謝を活性化させる化粧
料として、特開昭59−110608号公報や特開昭5
9−95210号公報に記載された化粧料が提案されて
いる。Therefore, as a cosmetic that is easily absorbed through the skin and activates skin metabolism by supplying physiologically active substances to the skin, JP-A-59-110608 and JP-A-5
A cosmetic described in Japanese Patent No. 9-95210 has been proposed.
しかしながら、これらの公報に記載された化粧料は、い
ずれも確かに皮膚の新陳代謝を活性化する効果を発現す
るものであるが、チロシナーゼの活性を抑制し、保湿効
果および美白効果を同時に充分に発現するものではない
。However, although all of the cosmetics described in these publications do have the effect of activating skin metabolism, they do not suppress tyrosinase activity and sufficiently exhibit moisturizing and whitening effects at the same time. It's not something you do.
[発明か解決しようとする課i]
そこで本発明者らは、前記従来技術に鑑みてシミ、ソバ
カスに有効なすぐれたモイスチャー効果やエモリエント
効果を皮膚に付与し、チロシナーゼの活性を抑制し、保
湿効果および美白効果を同時に発揮する化粧料をうろこ
とを目的として鋭意研究を重ねた結果、意外なことに、
腹足類(ただし、内臓を除く)からんられた抽出物は、
これらの効果をすべて同時に発揮【2、さらにはかかる
抽出物が頭髪保護効果および浴剤としての保温効果を発
揮することを見出l−1本発明を完成するにいたった。[Problem to be solved by the invention i] Therefore, in view of the above-mentioned prior art, the present inventors have provided the skin with an excellent moisturizing effect and emollient effect that is effective for stains and freckles, suppressing the activity of tyrosinase, and providing a moisturizing effect. As a result of intensive research aimed at developing cosmetics that have both effective and whitening effects, surprisingly,
Extracts from gastropods (excluding internal organs) are
All of these effects are exhibited at the same time [2] Furthermore, it was discovered that such an extract exhibits a hair protection effect and a heat-retaining effect as a bath additive.1-1 The present invention was completed.
[課題を解決するための手段コ
すなわち、本発明は腹足類(たたし、内臓を除く)から
えられた抽出物か配合されてなる化粧料に関する。[Means for Solving the Problems] In other words, the present invention relates to a cosmetic containing an extract obtained from gastropods (excluding snails and internal organs).
[作用および実施例]
本発明に用いられる腹足類(たたし、内臓を除く)から
えられた抽出物中の成分については未だ定かではないが
、本発明者らの研究によれば、該抽出物中に水溶性蛋白
などが含まれていることが確認されている。そして、こ
れらの各種成分が、本発明において目的とする化粧効果
を発現するものと思われる。[Operations and Examples] Although the components in the extract obtained from gastropods (excluding snails and internal organs) used in the present invention are not yet clear, according to the research of the present inventors, the extract It has been confirmed that these substances contain water-soluble proteins. It is believed that these various components exert the cosmetic effects aimed at in the present invention.
本発明に用いられる腹足類(たたし、内臓を除く)とし
ては、たとえばアワビ、サザエ、トコブシ、ツメタガイ
、タマキビ、ポラガイ、アメフラシ、ラミウシ、タニシ
、カタツムリ、ナメクジなどがあげられるが、本発明は
かかる例示のみに限定されるものではない。Examples of gastropods (excluding snails and internal organs) used in the present invention include abalones, turban shells, tokobushi, claw snails, snails, snails, Aplysia snails, laminas, snails, snails, and slugs. The examples are not limited to examples only.
本発明に用いられる腹足類(ただし、内臓を除く)から
えられた抽出物としては、たとえば新鮭な腹足類(たた
し、内臓を除く)や新鮭な状態で冷凍された腹足類(た
だし、内蔵を除く)などを抽出用の溶媒に浸漬し、抽出
することによりえられた抽出液、該抽出液が濃縮された
濃縮抽出液、前記抽出液を凍結乾燥またはスプレドライ
してえられる粉体、顆粒□や粒子状物などがあげられ、
本発明はかかる抽出物の形態によって限定されるもので
はない。Extracts obtained from gastropods (excluding internal organs) used in the present invention include, for example, fresh salmon gastropods (excluding internal organs) and gastropods frozen in fresh salmon state (excluding internal organs). Extract obtained by immersing and extracting (except for Examples include granules□ and particulate matter,
The present invention is not limited by the form of such extracts.
前記抽出物を調製する方法としては、種々の方法がある
が、その方法の一例をあげれば、たとえば腹足類(ただ
し、内臓を除く)を細切りし、これを後述する抽出用の
溶媒に浸漬し、加温I、なから抽出する方法などがあげ
られるか、本発明はかかる方法に限定されるものではな
い。There are various methods to prepare the extract, but one example is to cut a gastropod (excluding internal organs) into thin pieces, immerse it in an extraction solvent described below, The present invention is not limited to such methods, but may include methods such as heating I and extraction from scratch.
前記抽出用の溶媒としては、たとえば水;クエン酸ナト
リウム水溶液;メタノール、エタノルなどの低級アルコ
ール類;エチレングリコル、プロピレングリコール、グ
リセリン、13−ブチレングリコールなどのポリオール
類、オレイルアルコール、ステアリルアルコール、オク
チルドデカノールなどの高級アルコール類。Examples of the extraction solvent include water; aqueous sodium citrate solution; lower alcohols such as methanol and ethanol; polyols such as ethylene glycol, propylene glycol, glycerin, and 13-butylene glycol, oleyl alcohol, stearyl alcohol, and octyl alcohol. Higher alcohols such as dodecanol.
アセトンなどのケトン類;酢酸エチルなとのエステル類
:ヘキサン、ジクロロメタン、ベンゼン、トルエン、エ
ーテル類などの炭化水素系溶剤などがあげられ、これら
は単独でまたは2種以上を混合して用いられる。これら
のなかでは化粧料への幅広い適用という点て水または水
溶性の溶剤が好ましく、なかでもとくに水、エタノール
、グリセリン、1,3−ブチレングリコールが好ましい
。Examples include ketones such as acetone; esters with ethyl acetate; hydrocarbon solvents such as hexane, dichloromethane, benzene, toluene, and ethers; these may be used alone or in combination of two or more. Among these, water and water-soluble solvents are preferred from the viewpoint of wide application to cosmetics, and water, ethanol, glycerin, and 1,3-butylene glycol are particularly preferred.
なお、本発明において、抽出の際には、たとえばトリプ
シン、ペプシン、アクチナーゼ、グリシルグリシンベブ
チターゼ、カルボキシペブチターゼ、アミノベブチター
ゼ、パパイン、プロメライン、キモパパイン、キモトリ
プシンなどの蛋白分解酵素により、抽出物に処理が施さ
れることが、さらにチロシナーゼの活性を抑制するとい
う作用を呈するうえて好ましい。前記蛋白分解酵素の使
用量は、前記腹足類(ただし、内臓を除<)100部(
乾燥重量部、以下同様)に対して10〜50部、なかん
づ<20〜30部であることが好ましい。かかる使用量
か前記範囲未満であるばあい、蛋白の分解か不充分とな
り、前記抽出物が有する作用効果が減少する傾向があり
、また前記範囲をこえるばあい、必要量以上の添加は、
酵素の特性から考えても意味がない。In the present invention, during extraction, for example, proteolytic enzymes such as trypsin, pepsin, actinase, glycylglycine bebutitase, carboxypebutidase, aminobebutitase, papain, promelain, chymopapain, and chymotrypsin are used. It is preferable that the extract is subjected to a treatment in order to further exhibit the effect of suppressing the activity of tyrosinase. The amount of the protease used is 100 parts of the gastropod (excluding internal organs).
It is preferably 10 to 50 parts, preferably <20 to 30 parts, based on the dry weight (the same applies hereinafter). If the amount used is less than the above range, protein decomposition will be insufficient, and the effects of the extract will tend to decrease; if it exceeds the above range, adding more than the necessary amount will
It makes no sense considering the characteristics of the enzyme.
抽出時間は、溶媒の種類や抽出温度などにより異なるた
め、−概には決定することができないが、通常1〜48
時間、好ましくは10〜30時間である。また、抽出温
度は溶媒の種類などにより異なるため、−概には決定す
ることができないが、0℃以上であればよく、通常30
〜70℃であることが適当である。The extraction time varies depending on the type of solvent and extraction temperature, so it cannot be determined generally, but it is usually between 1 and 48
time, preferably 10 to 30 hours. In addition, since the extraction temperature varies depending on the type of solvent, etc., it cannot be determined generally, but it should be 0°C or higher, and usually 30°C or higher.
A suitable temperature is 70°C.
なお、えられた抽出液は、皮膚への安全性の点からpH
か4〜8程度に調整されることが好ましい。In addition, the pH of the obtained extract was adjusted to ensure safety for the skin.
It is preferable to adjust it to about 4 to 8.
かくしてえられる抽出物は、ヒトの肌に対してすぐれた
保湿作用およびチロシナーゼ活性抑制作用によるメラニ
ン生成抑制作用を有し、さらには湯に投入したばあいに
は入浴時や入浴後の体温の保温維持作用にすぐれたもの
である。The extract obtained in this way has an excellent moisturizing effect on human skin and an inhibitory effect on melanin production by suppressing tyrosinase activity.Furthermore, when added to hot water, it helps maintain body temperature during and after bathing. It has excellent maintenance effects.
本発明の化粧料は、前記抽出物を含有したものであるが
、該抽出物のほかにたとえば一般に化粧料に用いられて
いる賦形剤、香料などをはじめ、油脂類、界面活性剤、
保湿剤、p)I調整剤、増粘剤、防腐剤、酸化防止剤、
紫外線吸収剤、顔料、洗浄剤、乾燥剤、乳化剤などの各
種化粧料成分が適宜配合される。The cosmetics of the present invention contain the above-mentioned extracts, but in addition to the extracts, they may also contain, for example, excipients and fragrances commonly used in cosmetics, oils and fats, surfactants,
Humectants, p)I regulators, thickeners, preservatives, antioxidants,
Various cosmetic ingredients such as ultraviolet absorbers, pigments, detergents, desiccants, and emulsifiers are appropriately blended.
前記油脂類としては、一般に化粧料に汎用されるたとえ
ば流動パラフィン、パラフィン、セタノール、アボガド
油、オリーブ油、ホホバ油、ヤシ油などの植物性油:牛
脂、豚脂、馬脂、タトル油、ミンク油、パーセリン油、
スクワランなどの動物性油脂;メチルポリシロキサン、
ベヘニルアルコール、トリカプリルカプリン酸グリセリ
ル、トリオクタン酸グリセリル、トリイソパルミチン酸
グリセリン、シリコーンオイルなどの合成油脂などがあ
げられる。The oils and fats include vegetable oils commonly used in cosmetics, such as liquid paraffin, paraffin, cetanol, avocado oil, olive oil, jojoba oil, and coconut oil; beef tallow, lard, horse tallow, tuttle oil, and mink oil. , parcellin oil,
Animal fats and oils such as squalane; methylpolysiloxane,
Examples include behenyl alcohol, glyceryl tricaprylcaprate, glyceryl trioctanoate, glyceryl triisopalmitate, and synthetic oils and fats such as silicone oil.
前記界面活性剤としては、たとえばラウリル硫酸ナトリ
ウム、ラウリル硫酸トリエタノールアミン、ラウリン酸
ジェタノールアミドなどの陰イオン性界面活性剤;ステ
アリルトリメチルアンモニウムクロライド、セチルトリ
メチルアンモニウムクロライド、塩化ベンザルコニウム
などの陽イオン性界面活性剤;グリセリルモノステアレ
ート、ソルビタンモノステアレート、ポリオキシエチレ
ン■ソルビタンモノステアレート、ポリオキシエチレン
硬化しマシ油、ショ糖エステル、脂肪酸アミドなどの非
イオン性界面活性剤などがあげられる。Examples of the surfactant include anionic surfactants such as sodium lauryl sulfate, triethanolamine lauryl sulfate, and jetanolamide laurate; cationic surfactants such as stearyltrimethylammonium chloride, cetyltrimethylammonium chloride, and benzalkonium chloride; Nonionic surfactants such as glyceryl monostearate, sorbitan monostearate, polyoxyethylene sorbitan monostearate, polyoxyethylene hardened mustard oil, sucrose ester, fatty acid amide, etc. .
前記保湿剤としては、たとえばグリセリン、プロピレン
グリコール、1,3−ブチレングリコール、ピロリドン
カルボン酸ソーダなどの合成保湿剤;ヒアルロン酸、コ
ラーゲン、エラスチン、胎盤抽出液、ローヤルゼリー、
微生物発酵液などの天然保湿液などがあげられる。Examples of the moisturizer include synthetic moisturizers such as glycerin, propylene glycol, 1,3-butylene glycol, and sodium pyrrolidone carboxylate; hyaluronic acid, collagen, elastin, placenta extract, royal jelly,
Examples include natural moisturizing liquids such as microbial fermentation liquid.
前記pH調整剤としては、たとえばクエーン酸ナトリウ
ム、クエン酸などがあげられる。Examples of the pH adjuster include sodium citrate and citric acid.
前記増粘剤としては、たとえばカルボキシメチルセルロ
ース、ヒドロキシメチルセルロース、ヒドロキシエチル
セルロース、カルボキシビニルポリマー ポリビニルア
ルコール、トラガントガムなどがあげられる。Examples of the thickener include carboxymethylcellulose, hydroxymethylcellulose, hydroxyethylcellulose, carboxyvinyl polymer polyvinyl alcohol, and gum tragacanth.
前記防腐剤としては、たとえばメチルパラベン、エチル
パラベン、プロピルパラベン、ブチルパラベンなどのパ
ラオキシ安息香酸エステル、エタノール、デヒドロ酢酸
などがあげられる。Examples of the preservative include paraoxybenzoic acid esters such as methylparaben, ethylparaben, propylparaben, and butylparaben, ethanol, and dehydroacetic acid.
前記酸化防止剤としては、たとえばビタミンE1ブチル
オキシトルエン(BIT) 、プチルオキシアニゾール
(Bl(A)などがあげられる。Examples of the antioxidant include vitamin E1 butyloxytoluene (BIT) and butyloxyanisole (Bl(A)).
前記顔料としては、たとえばベンガラ、黄酸化鉄、黒酸
化鉄、酸化チタン、ナイロンパウダ、セリサイト、マイ
カ、タルクなどがあげられる。Examples of the pigment include red iron oxide, yellow iron oxide, black iron oxide, titanium oxide, nylon powder, sericite, mica, and talc.
前記洗浄剤としては、たとえば炭酸水素ナトリウムなど
があげられる。Examples of the cleaning agent include sodium hydrogen carbonate.
前記賦形剤としては、たとえば硫酸ナトリウムなどがあ
げられる。Examples of the excipient include sodium sulfate.
前記乳化剤としては、たとえば大豆レシチン油などがあ
げられる。Examples of the emulsifier include soybean lecithin oil.
これらの化粧料成分の各配合量は目的とする化粧料の用
途などにより異なるため、−概には決定することができ
ず、用途に応じて適宜調整されることが好ましい。The amount of each of these cosmetic ingredients varies depending on the intended use of the cosmetic, and therefore cannot be determined generally, and is preferably adjusted as appropriate depending on the intended use.
かくしてえられる本発明の化粧料は、肌に潤いを与え、
シミ、ソバカス、シワなどを防止するなどのすぐれた性
質を有するものであるので、たとえばクリーム、乳液、
ローション、洗顔料、バックなどの基礎化粧品、口紅、
ファンデーションなどのメイクアップ化粧品、ボディー
ソーブ、石鹸などのトイレタリー製品、浴剤などの形態
に調製して用いられる。The thus obtained cosmetic of the present invention moisturizes the skin,
It has excellent properties such as preventing stains, freckles, wrinkles, etc., so it can be used for example in creams, milky lotions, etc.
Basic cosmetics such as lotions, face washes, bags, lipsticks,
It is prepared and used in the form of makeup cosmetics such as foundation, toiletry products such as body wash and soap, and bath additives.
また、本発明の化粧料は頭髪に対しても毛根周辺の環境
改善および頭髪への直接的な作用により、枝毛や切れ毛
の防止、頭髪保護にも有効であるので、たとえばヘアー
トニック、ヘアリキッド、ヘアーブロー剤、ヘアーセッ
トロション、ヘアークリームなどの頭髪用製品やシャン
プー リンス、ヘアートリートメントなど頭髪用トイレ
タリー製品に適宜調製することかできるものである。In addition, the cosmetics of the present invention are effective for preventing split ends and hair breakage and protecting the hair by improving the environment around the hair roots and acting directly on the hair. It can be appropriately prepared into hair products such as liquid, hair blow agent, hair setting lotion, hair cream, and hair toiletry products such as shampoo conditioner and hair treatment.
前記抽出物の化粧料への配合量は、化粧料の種類などに
より異なるので一概には決定する二とができないか、そ
の−例をあげれば、たとえば化粧料100部(重量部、
以下同様)に対して抽出物の固形分換算で0.[)1〜
90部、好ましくは0.5〜50部であることが望まし
い。かかる配合量は前記範囲未満であるばあいには、前
記抽出物を配合したことによる効果が小さくなる傾向が
あり、また前記範囲をこえるばあいには、それ以上の効
果の向上は望めない。The amount of the extract to be added to cosmetics varies depending on the type of cosmetic, so it cannot be determined unconditionally.
(the same applies below), the solid content of the extract is 0. [)1~
It is desirable that the amount is 90 parts, preferably 0.5 to 50 parts. If the blending amount is less than the above-mentioned range, the effect of blending the extract tends to be reduced, and if it exceeds the above-mentioned range, no further improvement in the effect can be expected.
また、前記抽出物およびその乾燥粉末は、前記のごとく
、湯に投入したばあいに体温の保持効果にすぐれている
ことから、本発明の化粧料は浴剤とし、て好適に使用し
うるちのである。このように本発明の化粧料を浴剤とし
て使用するばあいには、抽出物の化粧料への配合量は、
化粧料100部に対して抽出物の固形分換算で0.1〜
90部、好ましくは20〜60部とすることか望ましい
。前記浴剤を使用するばあいには、該浴剤の使用量は、
通常湯200gに対して浴剤を5〜25g程度となるよ
うに調整することが好ましい。In addition, as mentioned above, the extract and its dry powder have an excellent effect of retaining body temperature when added to hot water, so the cosmetic composition of the present invention is suitable for use as a bath additive. It is. In this way, when the cosmetic of the present invention is used as a bath agent, the amount of extract added to the cosmetic is as follows:
0.1 to 100 parts of cosmetics in terms of solid content of extract
It is desirable that the amount is 90 parts, preferably 20 to 60 parts. When using the bath additive, the amount of the bath additive used is:
It is preferable to adjust the amount of bath agent to about 5 to 25 g per 200 g of normal hot water.
つぎに本発明の化粧料を実施例に基づいてさらに詳細に
説明するが、本発明はかかる実施例のみに限定されるも
のではない。Next, the cosmetic composition of the present invention will be explained in more detail based on Examples, but the present invention is not limited to these Examples.
調製例1(サザエの内臓を除いた部分の抽出液の製造)
新鮮なサザエから貝殻および内臓部を除いた部分を細切
りしたのち、エチルアルコールに浸漬して脱脂し、乾燥
【またのち、えられた乾燥物1 kgを弱アルカリ性に
調整したクエン酸ナトリウム水溶液50gに浸漬した。Preparation Example 1 (Production of extract of turban shell excluding internal organs) After removing the shell and internal organs from a fresh turban shell, it is cut into thin pieces, soaked in ethyl alcohol to degrease, and dried [later, harvested]. 1 kg of the dried product was immersed in 50 g of a slightly alkaline aqueous sodium citrate solution.
つぎに、この水溶液に蛋白分解酵素としてトリプシン2
50gを添加し7.55℃に加温しながら約6時間抽出
したのち、10%乳酸水溶液を添加してpHを7.0に
調整し、濾過精製して無色透明の抽出液(固形分含量約
4重量%) 45kgをえた。Next, trypsin 2 as a proteolytic enzyme is added to this aqueous solution.
After adding 50g and extracting for about 6 hours while heating to 7.55℃, 10% lactic acid aqueous solution was added to adjust the pH to 7.0, and filtered and purified to obtain a colorless and transparent extract (solid content Approximately 4% by weight) I gained 45kg.
調製例2(トコブシの内臓を除いた部分の抽出液の製造
)
→ノーザエのかわりに新紅なトコブシから貝殻および内
臓部を除いた部分を用いたほかは調製例1と同様にして
無色透明の抽出液(固形分&ffi約4重約4冫量5眩
をえた。Preparation Example 2 (Manufacture of an extract of the part of the tokobushi excluding the internal organs) → A colorless and transparent extract was prepared in the same manner as in Preparation Example 1, except that the part of the tokobushi with the shell and internal organs removed was used instead of the tokobushi. Extract liquid (solid content & ffi: about 4 times).
調製例3(アメフラシの内臓を除いた部分の抽出液の製
造)
サザエのかわりに新鮮なアメフラシから貝殻および内臓
部を除いた部分を用いたほかは調製例1と同様にして無
色透明の抽出液(固形分含量約4重量%) 45kgを
えた。Preparation Example 3 (Manufacture of extract of Aplysia Aplysia, excluding internal organs) A colorless and transparent extract was prepared in the same manner as Preparation Example 1, except that fresh Aplysia, excluding shells and internal organs, was used instead of turban shell. (Solid content: about 4% by weight) 45 kg was obtained.
調製例4(アワビの内臓を除いた部分の抽出液の製造)
新鮮なアワビから貝殻および内臓部を除いた部分を細断
し、アセトンに浸漬して脱脂したのち、えられた乾燥物
1kgを1.3−ブチレングリコルを10%含何する弱
アルカリ性水溶液50ρに浸漬17た。かかる水溶液に
蛋白分解酵素としてトリプシン250gを添加し、60
℃に加温しながら約6時間抽出したのち、10%リン酸
水溶液を添加してpHを6.0に調整し7、濾過精製し
て無色透明の抽出液(固形分含量約4重量%) 45k
gをえた。Preparation Example 4 (Production of extract of abalone excluding internal organs) After removing the shell and internal organs from a fresh abalone, shred it, soak it in acetone to degrease it, and then add 1 kg of the resulting dried product. It was immersed in 50 ρ of a weakly alkaline aqueous solution containing 10% 1.3-butylene glycol. 250 g of trypsin as a proteolytic enzyme was added to this aqueous solution, and 60 g of trypsin was added as a protease.
After extraction for about 6 hours while heating to ℃, 10% aqueous phosphoric acid solution was added to adjust the pH to 6.07, and the extract was purified by filtration to produce a colorless and transparent extract (solid content: about 4% by weight). 45k
I got g.
調製例5(ラミウシの内臓を除いた部分の抽出液の製造
)
アワビのかわりに新鮮なラミランから内臓部を除いた部
分を用いたほかは調製例4と同様にして無色透明の抽出
液(固形分含量約4重−%)45 kgをえた。Preparation Example 5 (Manufacture of an extract of the viscera of Lami slug) A colorless and transparent extract (solid The total weight was 45 kg (approximately 4% by weight).
調製例6(タニシの内臓を除いた部分の抽出液の製造)
アワビのかわりに新鮮なタニシから内臓部を除いた部分
を用いたほかは調製例4と同様にして無色透明の抽出液
(固形分含量約4重量%)45kgをえた。Preparation Example 6 (Production of extract of snail snail excluding internal organs) A colorless and transparent extract (solid 45 kg (content about 4% by weight) was obtained.
調製例7(サザエの内臓を除いた部分の抽出液の製造)
調製例1において、蛋白分解酵素を用いないほかは調製
例1と同様にして無色透明の抽出液(固形分含量約0.
1重量%)約45kgをえた。Preparation Example 7 (Manufacture of extract of turban shell excluding internal organs) A colorless and transparent extract (solid content of about 0.5%) was prepared in the same manner as in Preparation Example 1 except that no protease was used.
1% by weight) gained about 45 kg.
調製例8(トコブシの内臓を除いた部分の抽出液の製造
)
調製例2において、蛋白分解酵素を用いないほかは調製
例2と同様にして無色透明の抽出液(固形分含量約0.
1重量%)約45kgをえた。Preparation Example 8 (Manufacture of Extract from the Part of Tokobushi excluding Internal Organs) A colorless and transparent extract (solid content of about 0.0%) was prepared in the same manner as in Preparation Example 2 except that no protease was used.
1% by weight) gained about 45 kg.
調製例9(アメフラシの内臓を除いた部分の抽出液の製
造)
調製例3において、蛋白分解酵素を用いないほかは調製
例3と同様にして無色透明の抽出液(固形分含量約0.
1重量%)約45kgをえた。Preparation Example 9 (Production of Extract of Aplysia Aplysia Excluding Internal Organs) A colorless and transparent extract (solid content of about 0.00% was prepared in the same manner as in Preparation Example 3 except that no protease was used).
1% by weight) gained about 45 kg.
調製例10(アワビの内臓を除いた部分の抽出液の製造
)
調製例4において、蛋白分解酵素を用いないほかは調製
例4と同様にして無色透明の抽出液(固形分含量約0.
1重量%)約45kgをえた。Preparation Example 10 (Manufacture of Extract of Abalone Excluding Internal Organs) A colorless and transparent extract (solid content of about 0.0%) was prepared in the same manner as in Preparation Example 4, except that no protease was used.
1% by weight) gained about 45 kg.
調製例11(ラミウシの内臓を除いた部分の抽出液の製
造)
調製例5において、蛋白分解酵素を用いないほかは調製
例5と同様にして無色透明の抽出液(固形分含量約0.
1重量%)約45kgをえた。Preparation Example 11 (Manufacture of Extract of Rami Slug Excluding Internal Organs) A colorless and transparent extract (with a solid content of about 0.5%) was prepared in the same manner as in Preparation Example 5, except that no protease was used in Preparation Example 5.
1% by weight) gained about 45 kg.
調製例12(タニシの内臓を除いた部分の抽出液の製造
)
調製例6において、蛋白分解酵素を用いないほかは調製
例6と同様にして無色透明の抽出液(固形分含量約0.
1重量%)約45kgをえた。Preparation Example 12 (Production of Extract of Snail Snail Excluding Internal Organs) A colorless and transparent extract (solid content of approximately 0.00% was prepared in the same manner as Preparation Example 6 except that no protease was used).
1% by weight) gained about 45 kg.
参考例1〜13
調製例1〜12でえられた抽出液をサンプルとして用い
て以下に示す試験を行なった。Reference Examples 1 to 13 The following tests were conducted using the extracts obtained in Preparation Examples 1 to 12 as samples.
(1)チロシナーゼ活性抑制作用(チロシナーゼ反応法
)
チロシナーゼ(2200単位) 1.oigを正確に
秤量し、リン酸緩衝液(pH8,8) 2.Omlに
溶解してチロシナーゼ溶液を調製した。(1) Tyrosinase activity inhibition effect (tyrosinase reaction method) Tyrosinase (2200 units) 1. Accurately weigh the oig and add phosphate buffer (pH 8,8) 2. A tyrosinase solution was prepared by dissolving in Oml.
つぎに、各調製例でえられた抽出液を10倍に希釈した
水溶液0.8mlを正確に秤量し、これに0.05%L
−チロシン溶液1.0mlおよびリン酸緩衝液(pH6
,8) 1.Omlを加えて充分に撹拌して混合した
。この液に前記チロシナーゼ溶液0.2mlを加えて充
分に撹拌して混合し、この溶液の波長475nImにお
ける吸光度をただちに測定したのち、37℃の恒温槽中
に入れた。Next, 0.8 ml of an aqueous solution obtained by diluting the extract obtained in each preparation example 10 times was weighed accurately, and 0.05% L
- 1.0 ml of tyrosine solution and phosphate buffer (pH 6)
,8) 1. Oml was added and thoroughly stirred to mix. 0.2 ml of the above tyrosinase solution was added to this solution and mixed by thorough stirring. The absorbance of this solution at a wavelength of 475 nIm was immediately measured, and then placed in a constant temperature bath at 37°C.
24分間経過後、恒温槽からこの溶液を取り出し、再び
波長475nmにおける吸光度を測定し、下式からチロ
シナーゼ活性指数を求めた。また、抽出液のかわりに水
を用いて同様に操作したものをブランクとした。その結
果を第1表に示す。After 24 minutes had elapsed, this solution was taken out from the thermostatic bath, the absorbance at a wavelength of 475 nm was measured again, and the tyrosinase activity index was determined from the following formula. In addition, a blank was prepared by performing the same operation using water instead of the extract. The results are shown in Table 1.
[チロシナーゼ活性指数コ
B
(式中、T24は試験開始から24分間経過後の抽出液
が添加された溶液の吸光度、B24は試験開始から24
分間経過後の抽出液のかわりに水が添加された溶液の吸
光度、Toは試験開始直後の抽出液が添加された溶液の
吸光度、Boは試験開始直後の抽出液のかわりに水が添
加された溶液の吸光度を示す。)
参考例14および15
調製例3でえられた抽出液および該抽出液の酸加水分解
物について、高速アミノ酸自動分析計(■日立製作新製
、品番: L8500 、生体試料分析用)を用いてア
ミノ酸分析を行なった。調製例3でえられた抽出液のア
ミノ酸分析結果を第2表に、該抽出液の酸加水分解物の
アミノ酸分析結果を第3表にそれぞれ示す。[Tyrosinase activity index CoB (where T24 is the absorbance of the solution to which the extract was added 24 minutes after the start of the test, and B24 is the absorbance of the solution 24 minutes after the start of the test.
The absorbance of the solution in which water was added instead of the extract after a minute has elapsed, To is the absorbance of the solution in which the extract was added immediately after the start of the test, and Bo is the absorbance of the solution in which water was added instead of the extract immediately after the start of the test. Indicates the absorbance of the solution. ) Reference Examples 14 and 15 The extract obtained in Preparation Example 3 and the acid hydrolyzate of the extract were analyzed using a high-speed amino acid automatic analyzer (Newly manufactured by Hitachi, product number: L8500, for biological sample analysis). Amino acid analysis was performed. The amino acid analysis results of the extract obtained in Preparation Example 3 are shown in Table 2, and the amino acid analysis results of the acid hydrolyzate of the extract are shown in Table 3.
第2表および第3表に示された結果から、調製例3でえ
られた抽出物には、遊離のアミノ酸がほとんど含まれず
、アミノ酸が結合蛋白となって存在していることがわか
る。From the results shown in Tables 2 and 3, it can be seen that the extract obtained in Preparation Example 3 contains almost no free amino acids, and the amino acids exist in the form of bound proteins.
U以下余白コ
処方例1 [クリ−ムコ
[(A)成分] (部)流動
パラフィン 9.0パラフイン
5.0セタノール
2.0グリセリルモノステアレート2.0
ポリオキシエチレン■ソルビタン
モノステアレート 5.0ブチルパラベ
ン 0.1[(B)成分]
調製例1でえられた抽出液 30.0グリセリン
5.0カルボキシメチルセルロ
ース 0.1メチルパラベン
0.1精製水 41.4[(
C)成分コ
香 料
0.8上記(A)成分および(B)成分をそれぞれ8
0℃以上に加熱後、かかる(A)成分および(B)成分
を混合撹拌した。これを50℃まで冷却後、上記(C)
成分を加えてさらに撹拌混合して均一なりリームを調製
した。Margin below U Prescription Example 1 [Cream Co [Component (A)] (Part) Liquid Paraffin 9.0 Paraffin
5.0 cetanol
2.0 Glyceryl monostearate 2.0 Polyoxyethylene Sorbitan monostearate 5.0 Butylparaben 0.1 [Component (B)] Extract obtained in Preparation Example 1 30.0 Glycerin 5.0 Carboxymethyl cellulose 0.1 methylparaben
0.1 Purified water 41.4 [(
C) Ingredient fragrance
0.8 Each of the above (A) component and (B) component
After heating to 0° C. or higher, the components (A) and (B) were mixed and stirred. After cooling this to 50°C, the above (C)
The ingredients were added and further stirred and mixed to prepare a uniform ream.
処方例2[乳液]
[(A)成分] (部)流動
パラフィン 10.00ホホバ油
1.00ポリオキシエチレン■
ソル
ビタンモノステアレート 2.00大豆レシチ
ン油 1.50メチルパラベン
0.15エチルパラベン
0.03[(B)成分コ
調製例3でえられた抽出液 ao、o。Formulation example 2 [Emulsion] [Component (A)] (Part) Liquid paraffin 10.00 Jojoba oil
1.00 polyoxyethylene■
Sorbitan monostearate 2.00 Soybean lecithin oil 1.50 Methylparaben
0.15 ethylparaben
0.03 [Component (B) extract obtained in Preparation Example 3 ao, o.
グリセリン 3,001.3−ブ
チレングリコール 2.00カルボキシメチ
ル
セルロースナトリウム 0.30精製水
49.97[(C)成分]
香料 0.05上記人成分
および([31成分をそれぞれlllO℃に加温したの
ち、混合撹拌した。これを50℃まで冷却後、上記fc
)成分を加えて撹拌し、均一な乳液を調製した。Glycerin 3,001.3-Butylene glycol 2.00 Sodium carboxymethyl cellulose 0.30 Purified water
49.97 [Ingredient (C)] Fragrance 0.05 The above human ingredients and ([31 ingredients were each heated to lllO ℃, then mixed and stirred. After cooling to 50 ℃, the above fc
) ingredients were added and stirred to prepare a homogeneous emulsion.
処方例3 [ローションコ
「成分コ (部)エタノール
10.0グリセリン
3.01.3−ブチレングリコール
2.0メチルパラベン 0
.2クエン酸 0.1クエン
酸ナトリウム 0.3カルボキシビニル
ポリマー 0.1調製例2でえられた抽出液
50.0香 料
微量精製水 全量が10
0.0部となる量
上記成分を混合して均一なローションを調製した。Prescription example 3 [Lotion Co "Ingredients (Part) Ethanol 10.0 Glycerin
3.01.3-Butylene glycol
2.0 Methylparaben 0
.. 2 Citric acid 0.1 Sodium citrate 0.3 Carboxyvinyl polymer 0.1 Extract obtained in Preparation Example 2
50.0 fragrance
Micro-purified water total amount is 10
A homogeneous lotion was prepared by mixing the above components in an amount of 0.0 part.
処方例4[バック]
「成分コ (部)ポリビニル
アルコール 15.0ヒドロキシメチルセル
ロース 5.0プロピレングリコール
5.0エタノール 10.
0メチルパラベン 0.1調製例3
でえられた抽出液 10.0香 料
微量精製水
全量が100.0部となる量
上記成分を混合撹拌して均一なバックを調製した。Formulation example 4 [Back] Ingredients (Part) Polyvinyl alcohol 15.0 Hydroxymethyl cellulose 5.0 Propylene glycol
5.0 Ethanol 10.
0 Methylparaben 0.1 Preparation Example 3
The resulting extract 10.0 fragrance
micro purified water
A uniform bag was prepared by mixing and stirring the above components in amounts such that the total amount was 100.0 parts.
処方例5[プレスパウダー]
調製例4でえられた抽出液を凍結乾燥粉末で水分除去す
ることにより、凍結乾燥し、これをボールミルにより粉
砕して粉末(粒度約30道以下)をえ、かかる粉末を用
いた。Formulation Example 5 [Pressed Powder] The extract obtained in Preparation Example 4 is freeze-dried by removing water with a freeze-dried powder, and this is ground by a ball mill to obtain a powder (particle size of about 30 mm or less), Powder was used.
[(A)成分] (部)ベン
ガラ 0.5黄酸化鉄
1.5黒酸化鉄
0.1酸化チタン 1
0.0ナイロンパウダー 4゜0セリ
サイト 28,0マイカ
23,0タルク
25,0調製例4でえられた
抽出液の凍結乾燥粉末 0.7[[B)成分]
スクワラン 1.0メチルポリ
シロキザン 4,0プロピルパラベン
0.1デヒドロ酢酸
0.1流動パラフイン 2.0香
料 微量
上記(A)成分および(B)成分をそれぞれ混合撹拌し
、かかる(A)成分および(B)成分を混合したのち、
200メツシユのタイラーメッシュの篩にかけて金型に
打型して均一なプレスパウダーを調製した。[(A) Component] (Part) Red iron 0.5 yellow iron oxide
1.5 black iron oxide
0.1 titanium oxide 1
0.0 nylon powder 4゜0 sericite 28.0 mica
23,0 talc
25.0 Freeze-dried powder of the extract obtained in Preparation Example 4 0.7 [[B] Component] Squalane 1.0 Methylpolysiloxane 4,0 Propylparaben
0.1 dehydroacetic acid
0.1 Liquid paraffin 2.0 Fragrance Small amount The above (A) component and (B) component are mixed and stirred, and after mixing the (A) component and (B) component,
A uniform pressed powder was prepared by passing through a 200-mesh Tyler mesh sieve and pressing into a mold.
処方例6[シャンプー]
調製例3でえられた抽出液を処方例5と同様の操作によ
り凍結乾燥し、粉砕してえられた粉末(粒度約30.L
a以下)を用いた。Formulation Example 6 [Shampoo] The extract obtained in Preparation Example 3 was freeze-dried in the same manner as in Formulation Example 5, and a powder obtained by pulverization (particle size of approximately 30.L)
a below) was used.
[成分] (部)ラウリル硫
酸トリエタノール
アミン 15.0ラウリン酸ジエ
タノール
ア ミ ド
5.0メチルバラヘン
0.1プロピルパラベン
0.1調製例3でえられた
抽出液の凍結乾燥粉末 0.5香 料
微量精製水
全量が100.0部となる量
上記成分を混合撹拌して均一なシャンプーを調製した。[Ingredients] (Part) Lauryl sulfate triethanolamine 15.0 Lauric acid diethanolamide
5.0 Methylvarachen
0.1 propylparaben
0.1 Freeze-dried powder of the extract obtained in Preparation Example 3 0.5 Flavor
micro purified water
A uniform shampoo was prepared by mixing and stirring the above ingredients in amounts such that the total amount was 100.0 parts.
処方例7[ヘアーセットローション]
調製例2でえられた抽出液をスプレードライの操作によ
り乾燥粉末化してえられた粉末(粒度的100−以下)
を用いた。Prescription Example 7 [Hair Set Lotion] Powder obtained by drying and powdering the extract obtained in Preparation Example 2 by spray drying (particle size: 100- or less)
was used.
[成分] (部)トラガント
ガム 2.0グリセリン
1.0エタノール
20.0メチルパラベン 0.2
調製例2でえられた
抽出液の凍結乾燥粉末 0.5香 料
微量精製水
全量が100.0部となる量
上記成分を混合撹拌して均一なヘアーセットローション
をえた。[Ingredients] (Part) Gum tragacanth 2.0 Glycerin
1.0 ethanol
20.0 Methylparaben 0.2
Freeze-dried powder of extract obtained in Preparation Example 2 0.5 Flavor
micro purified water
The above ingredients were mixed and stirred in such amounts that the total amount was 100.0 parts to obtain a uniform hair setting lotion.
処方例8[ヘアーリンス]
調製例1でえられた抽出液を処方例7と同様の操作によ
り凍結乾燥し、粉砕して粉末(粒度的100−以下)を
え、かかる粉末を用いた。Formulation Example 8 [Hair Rinse] The extract obtained in Preparation Example 1 was freeze-dried in the same manner as in Formulation Example 7, and pulverized to obtain a powder (particle size of 100- or less), which was used.
[(A)成分] (部)ベヘ
ニルアルコール 0.2セタノール
1.5ステアリルトリメチル
アンモニウムクロライド 2.0グリセリルモノ
ステアレート
(自己乳化型)2.0
ヘキサラン
(トリオクタン酸グリセリル、
共栄化学工業■製)1.0
調製例1でえられた
抽出液の凍結乾燥粉末 1.0[(B)成分]
ヒドロキシエチルセルロース 1.0メチルパラベ
ン 0.2グリセリン
3.0精製水 8
7.9[(C)成分]
香 料
0.2上記(A)成分および(B)成分をそれぞれ8
0℃以上に加熱後、混合撹拌した。50℃まで冷却後、
(C)成分を加えてさらに撹拌混合して均一なヘアーリ
ンスを調製した。[Component (A)] (Part) Behenyl alcohol 0.2 cetanol
1.5 Stearyltrimethylammonium chloride 2.0 Glyceryl monostearate (self-emulsifying type) 2.0 Hexalan (glyceryl trioctanoate, manufactured by Kyoei Kagaku Kogyo ■) 1.0 Freeze-dried powder of the extract obtained in Preparation Example 1 1.0 [Component (B)] Hydroxyethylcellulose 1.0 Methylparaben 0.2 Glycerin
3.0 Purified water 8
7.9 [(C) Component] Fragrance
0.2 Each of the above (A) component and (B) component
After heating to 0° C. or higher, the mixture was mixed and stirred. After cooling to 50℃,
Component (C) was added and further stirred and mixed to prepare a uniform hair rinse.
処方例9[浴剤コ
調製例3でえられた抽出液を処方例7と同様の操作によ
り凍結乾燥し、粉砕してえられた粉末(粒度約100項
以下)を用いた。Formulation Example 9 [Bath Salt] The extract obtained in Preparation Example 3 was freeze-dried in the same manner as in Formulation Example 7, and the resulting powder (particle size of about 100 particles or less) was used.
[成分] (部)硫酸ナトリ
ウム 47.0炭酸水素ナトリウム
47.0調製例3でえられた
抽出液の凍結乾燥粉末 6.0香 料
微量上記成分を
混合撹拌して均一な浴剤を調製した。[Ingredients] (Part) Sodium sulfate 47.0 Sodium hydrogen carbonate
47.0 Freeze-dried powder of the extract obtained in Preparation Example 3 6.0 Flavor
A uniform bath agent was prepared by mixing and stirring trace amounts of the above components.
処方例10 [クリ−ムコ
調製例1でえられた抽出液のかわりに調製例7でえられ
た抽出液を用いたほかは処方例1と同様にしてクリーム
を調製した。Formulation Example 10 [Cream was prepared in the same manner as Formulation Example 1 except that the extract obtained in Preparation Example 7 was used instead of the extract obtained in Creamco Preparation Example 1.
処方例11 [乳液]
調製例3でえられた抽出液のかわりに調製例9でえられ
た抽出液を用いたほかは、処方例2と同様にして乳液を
調製した。Formulation Example 11 [Emulsion] A milky lotion was prepared in the same manner as in Formulation Example 2, except that the extract obtained in Preparation Example 9 was used instead of the extract obtained in Preparation Example 3.
処方例12[ローション]
調製例2でえられた抽出液のかわりに調製例8でえられ
た抽出液を用いたほかは処方例3と同様にしてローショ
ンを調整した。Formulation Example 12 [Lotion] A lotion was prepared in the same manner as Formulation Example 3, except that the extract obtained in Preparation Example 8 was used instead of the extract obtained in Preparation Example 2.
処方例13[バック]
調製例3でえられた抽出液のかわりに調製例9でえられ
た抽出液を用いたほかは処方例4と同様にしてバックを
調製した。Formulation Example 13 [Bag] A bag was prepared in the same manner as Formulation Example 4 except that the extract obtained in Preparation Example 9 was used instead of the extract obtained in Preparation Example 3.
処方例14 [シャンプー]
調製例3でえられた抽出液のかわりに調製例10でえら
れた抽出液を用いたほかは処方例6と同様にしてシャン
プーを調製した。Formulation Example 14 [Shampoo] A shampoo was prepared in the same manner as Formulation Example 6 except that the extract obtained in Preparation Example 10 was used instead of the extract obtained in Preparation Example 3.
処方例15[ヘアーセットローション]調製例2でえら
れた抽出液のかわりに調製例11でえられた抽出液を用
いたほかは処方例7と同様にしてヘアーセットローショ
ンを調製した。Formulation Example 15 [Hair Setting Lotion] A hair setting lotion was prepared in the same manner as Formulation Example 7 except that the extract obtained in Preparation Example 11 was used instead of the extract obtained in Preparation Example 2.
処方例1B [ヘアーリンス]
調製例11でえられた抽出液のかわりに調製例12でえ
られた抽出液を用いたほかは処方例8と同様にしてヘア
ーリンスを調製した。Formulation Example 1B [Hair Rinse] A hair rinse was prepared in the same manner as Formulation Example 8 except that the extract obtained in Preparation Example 12 was used instead of the extract obtained in Preparation Example 11.
比較処方例] [クリーム]
調製例1でえられた抽出液のかわりに精製水を用いたほ
かは処方例1と同様にしてクリームを調製した。Comparative Prescription Example] [Cream] A cream was prepared in the same manner as Preparation Example 1 except that purified water was used instead of the extract obtained in Preparation Example 1.
比較処方例2[乳液コ
調製例3でえられた抽出液のかわりに精製水を用いたほ
かは処方例2と同様にして乳液を調製した。Comparative Prescription Example 2 [Emulsion Co] An emulsion was prepared in the same manner as Preparation Example 2, except that purified water was used instead of the extract obtained in Preparation Example 3.
比較処方例3[ローションコ
調製例2でえられた抽出液のかわりに精製水を用いたほ
かは処方例3と同様にしてローションを調製した。Comparative Prescription Example 3 [Lotion Co. A lotion was prepared in the same manner as Preparation Example 3 except that purified water was used instead of the extract obtained in Preparation Example 2.
比較処方例4[バラフコ
調製例3でえられた抽出液のかわりに精製水を用いたほ
かは処方例4と同様にしてバックを調製した。Comparative Formulation Example 4 [Barafco A bag was prepared in the same manner as Formulation Example 4 except that purified water was used instead of the extract obtained in Preparation Example 3.
比較処方例5[シャンプー]
調製例3でえられた抽出液のかわりに精製水を用いたほ
かは、処方例6と同様にしてシャンプーを調製した。Comparative Formulation Example 5 [Shampoo] A shampoo was prepared in the same manner as Formulation Example 6, except that purified water was used instead of the extract obtained in Preparation Example 3.
比較処方例6[ヘアーセットローション]調製例2てえ
られた抽出液のかわりに精製水を用いたほかは処方例7
と同様にしてヘアーセットローションを調製した。Comparative Prescription Example 6 [Hair Set Lotion] Preparation Example 7 except that purified water was used instead of the extract obtained from Preparation Example 2.
A hair setting lotion was prepared in the same manner as above.
比較処方例7「ヘアーリンスコ
調製例1でえられた抽出液のかわりに精製水を用いたほ
かは処方例8と同様にしてヘアーリンスを調製した。Comparative Prescription Example 7 "Hair Rinsco" A hair rinse was prepared in the same manner as Preparation Example 8 except that purified water was used instead of the extract obtained in Preparation Example 1.
比較処方例8[浴剤]
調製例3てえられた抽出液のかわりに精製水を用いたほ
かは処方例9と同様に(2て浴剤を調製した。Comparative Formulation Example 8 [Bath Agent] A bath agent was prepared in the same manner as in Formulation Example 9 (2) except that purified water was used instead of the extract obtained in Preparation Example 3.
実施例1
処方例1〜4および10〜13ならびに比較処方例1〜
4でえられた化粧料についてそれぞれ以下に示すモニタ
ーテストを行なった。その結果を第4表に示す。Example 1 Prescription Examples 1-4 and 10-13 and Comparative Prescription Examples 1-
The following monitor tests were conducted on each of the cosmetics obtained in step 4. The results are shown in Table 4.
(モニターテスト)
無作為に抽出した年齢18〜55歳の女性100名を対
象として各化粧料を顔面頬部の皮膚に塗布したときのモ
イスチャー効果、エモリエント効果および肌のつやにつ
いて以下の判定基準に基づき、評価を行なった。(Monitor test) The moisturizing effect, emollient effect, and skin luster when each cosmetic was applied to the skin of the face and cheeks were evaluated according to the following criteria for 100 randomly selected women aged 18 to 55. The evaluation was conducted based on the following.
[モイスチャー効果]
A:非常にしっとりしている
B:なんとなくしっとりしている
C:普通
り二あまりしっとりした感じがない
E:まったくしっとりした感じがない
[エモリエント効果]
A:非常に柔軟で感触がよい
B:なんとなく柔軟で感触がよい
C:普通
り二あまり柔軟さを感じず、感触がよくないE:まった
く柔軟さを感じず、感触がよくない
[肌のつや]
A:非常につややかになった
B:なんとなくつややかになった
C:変化なし
D:なんとなくつややかさかなくなったE:明らかにつ
ややかさがなくなった
なお、モニターテストの結果、皮膚に異常を訴えた者は
いなかった。[Moisture effect] A: Very moist B: Somehow moist C: Not very moist feeling compared to average E: No moist feeling at all [Emollient effect] A: Very soft and pleasant to the touch Good B: Somewhat soft and good to the touch C: Average to average Not very flexible and has a good feel E: Not at all flexible and has a poor feel [Skin gloss] A: Very shiny B: Somehow became shiny C: No change D: Somehow lost luster E: Clearly lost luster Furthermore, as a result of the monitor test, no one complained of any skin abnormality.
[以下余白]
実施例2
処方例6〜8および14〜IBならびに比較処方例5〜
7でえられた頭髪用化粧品についてそれぞれ以下に示す
ハーフヘッドテストを行なった。[Margin below] Example 2 Prescription Examples 6 to 8 and 14 to IB and Comparative Prescription Example 5 to
The hair cosmetics obtained in step 7 were subjected to the following half-head test.
その結果を第5表に示す。The results are shown in Table 5.
(ハーフヘッドテスト)
無作為に抽出した年齢18〜60歳の男性20名を対象
として各頭髪用化粧料を頭髪に1日2回、30日間使用
したのちの頭髪のつややかさ、しっとり感およびくし通
りについて以下の判定基準に基づき、評価を行なった。(Half-head test) 20 randomly selected men between the ages of 18 and 60 used each hair cosmetic twice a day for 30 days. The street was evaluated based on the following criteria.
[つややかさ]
A:非常につややかになった
B:なんとなくつややかになった
C:変化なし
D:なんとなくつややかさがなくなったE:まったくつ
ややかさがなくなった
[しっとり感]
A:非常にしっとりして感じがよくなったB:なんとな
くしっとりして感じがよくなっC:変化なし
D=あまりしっとり感が感じられなくなったE:まった
くしっとり感が感じられなくなった
[<シ通り〕
A:非常によくなった
B:なんとなくよくなった
C:変化なし
D:なんとなくわるくなった
E:まったくわるくなった
なお、ハーフヘッドテストの結果、頭髪や頭皮に異常を
訴えた者はいなかった。[Shininess] A: Very shiny B: Somehow shiny C: No change D: Somehow lost gloss E: No shiny at all [Moist feeling] A: Very moist The feeling has improved B: It has somehow become moisturized and feels better C: There has been no change D = It has not felt so moist E: It has not felt moist at all [<Exactly] A: It has improved very much. B: Somewhat improved C: No change D: Somewhat worse E: Completely worse In addition, as a result of the half-head test, no one complained of any abnormality with their hair or scalp.
[以下余白]
実施例3
処方例9および比較処方例8でえられた浴剤についてそ
れぞれ以下に示すモニターテストを行なった。その結果
を第6表に示す。[Left below] Example 3 The following monitor tests were conducted on the bath additives obtained in Formulation Example 9 and Comparative Formulation Example 8. The results are shown in Table 6.
(モニターテスト)
無作為に抽出した年齢30〜60歳の女性20名を対象
として入浴中に各浴剤を湯200Ilに対して25g使
用したばあいに、入浴後20℃、湿度65%における部
屋で15分間休息後の体温の保温効果について以下の判
定基準に基づいて評価を行なった。(Monitor test) 20 randomly selected women aged 30 to 60 were given 25 g of each bath salt per 200 Il of hot water while taking a bath. The effectiveness of keeping body temperature after a 15-minute rest was evaluated based on the following criteria.
(保温効果)
A:非常に暖かさを感じる
B:心地よい暖かさを感じる
C:普通
D:わずかに肌寒さを感じる
E:肌寒い
なお、モニターテストの結果、皮膚に異常を訴えた者は
いなかった。(Heat retention effect) A: Feels very warm B: Feels pleasantly warm C: Average D: Feels slightly chilly E: Chilly However, as a result of the monitor test, no one complained of any skin abnormalities. .
第
表
[発明の効果]
本発明に用いられる腹足類(たたし、内臓を除く)から
えられた抽出物、なかでも蛋白分解酵素処理が施された
抽出物は、高い保湿力を有し、しかもチロシナーゼ活性
を抑制する作用を有することから、これか配合された本
発明の化粧料は、皮膚に対してすぐれたモイスチャー効
果とエモリエント効果を発揮し、保湿および美白といっ
た総合的な化粧効果を奏する。Table 1 [Effects of the Invention] The extract obtained from gastropods (excluding snails and internal organs) used in the present invention, especially the extract treated with proteolytic enzymes, has high moisturizing power, Moreover, since it has the effect of suppressing tyrosinase activity, the cosmetics of the present invention containing this compound exhibit excellent moisturizing and emollient effects on the skin, and provide comprehensive cosmetic effects such as moisturizing and whitening. .
また、本発明の化粧料は、浴剤として用いたばあいには
、入浴中および入浴後の体温の保温効果にすぐれたもの
である。Furthermore, when the cosmetic of the present invention is used as a bath agent, it has an excellent effect of keeping body temperature during and after bathing.
さらには、本発明の化粧料は、頭髪用の化粧料として用
いたばあいには、枝毛や切れ毛の防止、頭髪保護などの
効果を奏する。Furthermore, when the cosmetic of the present invention is used as a hair cosmetic, it exhibits effects such as preventing split ends and hair breakage and protecting the hair.
Claims (1)
が配合されてなる化粧料。 2 抽出物が、蛋白分解酵素処理が施されたものである
請求項1記載の化粧料。[Claims] 1. A cosmetic containing an extract obtained from gastropods (excluding internal organs). 2. The cosmetic according to claim 1, wherein the extract has been treated with a proteolytic enzyme.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2173650A JP3044690B2 (en) | 1990-06-30 | 1990-06-30 | Cosmetics |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2173650A JP3044690B2 (en) | 1990-06-30 | 1990-06-30 | Cosmetics |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JPH0466514A true JPH0466514A (en) | 1992-03-02 |
| JP3044690B2 JP3044690B2 (en) | 2000-05-22 |
Family
ID=15964547
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2173650A Expired - Lifetime JP3044690B2 (en) | 1990-06-30 | 1990-06-30 | Cosmetics |
Country Status (1)
| Country | Link |
|---|---|
| JP (1) | JP3044690B2 (en) |
Cited By (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP2009521524A (en) * | 2005-12-27 | 2009-06-04 | ジョン・ヒュン・ナム | Cosmetic composition for skin whitening, beauty pack using the same, and method for producing the same |
| CN105606637A (en) * | 2015-12-17 | 2016-05-25 | 大连工业大学 | Method for detecting water content and fat content in abalone through low-field nuclear magnetic resonance technology |
| CN111317705A (en) * | 2018-12-17 | 2020-06-23 | 扬州蓝色生物医药科技有限公司 | Snail extract for inhibiting melanin growth and its application in preparation of daily chemical products |
Families Citing this family (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| KR102016909B1 (en) * | 2017-12-29 | 2019-09-02 | (주)대한뷰티산업진흥원 | Cosmetic composition for whitening and anti-wrinkle containing Batillus cornutus derived peptide powder |
| KR102912581B1 (en) * | 2023-11-30 | 2026-01-14 | 한국식품연구원 | Composition for hair health, hair growth promotion, hair loss preventing or improving containing hydrolyzate of Pomacea canaliculate |
-
1990
- 1990-06-30 JP JP2173650A patent/JP3044690B2/en not_active Expired - Lifetime
Cited By (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP2009521524A (en) * | 2005-12-27 | 2009-06-04 | ジョン・ヒュン・ナム | Cosmetic composition for skin whitening, beauty pack using the same, and method for producing the same |
| CN105606637A (en) * | 2015-12-17 | 2016-05-25 | 大连工业大学 | Method for detecting water content and fat content in abalone through low-field nuclear magnetic resonance technology |
| CN111317705A (en) * | 2018-12-17 | 2020-06-23 | 扬州蓝色生物医药科技有限公司 | Snail extract for inhibiting melanin growth and its application in preparation of daily chemical products |
| CN111317705B (en) * | 2018-12-17 | 2023-07-25 | 扬州蓝色生物医药科技有限公司 | Snail extract for inhibiting melanin growth and application thereof in preparing daily chemicals |
Also Published As
| Publication number | Publication date |
|---|---|
| JP3044690B2 (en) | 2000-05-22 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP3171637B2 (en) | Anti-aging cosmetics | |
| JP3576200B2 (en) | Whitening cosmetics | |
| JP3601875B2 (en) | Cosmetics | |
| JP2003048846A (en) | Collagenase inhibitor and anti-aging cosmetic | |
| JP3513872B2 (en) | External preparation for skin | |
| JP3499336B2 (en) | Anti-aging cosmetics | |
| JP3061295B2 (en) | Cosmetics | |
| JP2971549B2 (en) | Cosmetics | |
| JP3591950B2 (en) | Anti-aging cosmetics and SOD-like active agents used therefor | |
| JP3044690B2 (en) | Cosmetics | |
| JP2009249366A (en) | Collagen production promotor and anti-aging skin preparation for external use | |
| JP2604782B2 (en) | Cosmetics | |
| JP2003192567A (en) | Cosmetic | |
| JP2005145938A (en) | Active oxygen scavenger and cosmetic | |
| JP2015151388A (en) | cosmetic | |
| JP4621958B2 (en) | Cosmetic compounding agent and cosmetics containing the same | |
| KR100414903B1 (en) | Cosmetic composition containing medical plant complex extracts with antiwrinkle and whitening effect | |
| JP3818998B2 (en) | Whitening cosmetics | |
| JP2008100963A (en) | Cosmetics | |
| JPH05246826A (en) | Hair-care cosmetic | |
| JP2963136B2 (en) | Cosmetics | |
| JP4500906B2 (en) | Cosmetic compounding agent and cosmetics containing the same | |
| JPH09175980A (en) | Cosmetic | |
| JP2009234976A (en) | Cell activator and external preparation for skin for antiaging | |
| KR102888988B1 (en) | Foam cleansing composition comprising glycyrrhiza inflata root extract and houttuynia cordata extract |